An Early CD4+ T Cell-dependent Immunoglobulin A Response to Influenza Infection in the Absence of Key Cognate T-B Interactions
Overview
General Medicine
Authors
Affiliations
Contact-mediated interactions between CD4+ T cells and B cells are considered crucial for T cell-dependent B cell responses. To investigate the ability of activated CD4+ T cells to drive in vivo B cell responses in the absence of key cognate T-B interactions, we constructed radiation bone marrow chimeras in which CD4+ T cells would be activated by wild-type (WT) dendritic cells, but would interact with B cells that lacked expression of either major histocompatibility complex class II (MHC II) or CD40. B cell responses were assessed after influenza virus infection of the respiratory tract, which elicits a vigorous, CD4+ T cell-dependent antibody response in WT mice. The influenza-specific antibody response was strongly reduced in MHC II knockout and CD40 knockout mice. MHC II-deficient and CD40-deficient B cells in the chimera environment also produced little virus-specific immunoglobulin (Ig)M and IgG, but generated a strong virus-specific IgA response with virus-neutralizing activity. The IgA response was entirely influenza specific, in contrast to the IgG2a response, which had a substantial nonvirus-specific component. Our study demonstrates a CD4+ T cell-dependent, antiviral IgA response that is generated in the absence of B cell signaling via MHC II or CD40, and is restricted exclusively to virus-specific B cells.
Yong L, Hutchings C, Barnes E, Klenerman P, Provine N Eur J Immunol. 2024; 55(1):e202451142.
PMID: 39604225 PMC: 11739681. DOI: 10.1002/eji.202451142.
Bromley J, Ganchua S, Nyquist S, Maiello P, Chao M, Jacob Borish H Immunity. 2024; 57(10):2380-2398.e6.
PMID: 39214090 PMC: 11466276. DOI: 10.1016/j.immuni.2024.08.002.
CD4 T cells are homeostatic regulators during reinfection.
Bromley J, Ganchua S, Nyquist S, Maiello P, Chao M, Jacob Borish H bioRxiv. 2024; .
PMID: 38187598 PMC: 10769325. DOI: 10.1101/2023.12.20.572669.
The role of CD4 T cells in tumor and chronic viral immune responses.
Xie L, Fang J, Yu J, Zhang W, He Z, Ye L MedComm (2020). 2023; 4(5):e390.
PMID: 37829505 PMC: 10565399. DOI: 10.1002/mco2.390.
Elkhatib W, Abdelkareem S, Khalaf W, Shahin M, Elfadil D, Alhazmi A Virol J. 2022; 19(1):167.
PMID: 36280866 PMC: 9589879. DOI: 10.1186/s12985-022-01902-2.